CRVS
Corvus Pharmaceuticals Inc
NASDAQ: CRVS · HEALTHCARE · BIOTECHNOLOGY
$15.19
+5.34% today
Updated 2026-04-30
Market cap
$1.35B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$3 – $27
Volume
1.3M
Corvus Pharmaceuticals Inc (CRVS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-32.60%
ROA
-38.40%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $0.00 | $-176000.00 | — | — | — |
| 2015 | $0.00 | $-31.34M | — | — | — |
| 2016 | $0.00 | $-36.38M | — | — | — |
| 2017 | $0.00 | $-55.66M | — | — | — |
| 2018 | $0.00 | $-46.94M | — | — | — |
| 2019 | $0.00 | $-43.75M | — | — | — |
| 2020 | $0.00 | $-4.82M | — | — | — |
| 2021 | $0.00 | $-43.24M | — | — | — |
| 2022 | $0.00 | $-41.31M | — | — | — |
| 2023 | $0.00 | $-27.03M | — | — | — |
| 2024 | $0.00 | $-62.29M | — | — | — |
| 2025 | $0.00 | $-15.28M | — | — | — |